Strides Pharma Science gets EU-GMP certification for 2 manufacturing facilities `

Strides Pharma Science gets EU-GMP certification for 2 manufacturing facilities `

AgenciesUpdated: Thursday, June 16, 2022, 03:23 PM IST
article-image
Strides Pharma Science gets EU-GMP certification for 2 manufacturing facilities ` |

Strides Pharma Science on Thursday said its subsidiary has received EU-GMP certification for two of its manufacturing facilities from Hungary's National Institute of Pharmacy and Nutrition.

Stelis Biopharma, an emerging biopharmaceutical and vaccine Contract Development and Manufacturing Organisation (CDMO) and the biologics arm of Strides Pharma, has received the European Union Goods Manufacturing Practices (EU-GMP) certification for the two manufacturing plants.

"The approval from EU-GMP is a significant first step in our journey to build a global biologics CDMO platform that offers end-to-end solutions across the modalities," company founder Arun Kumar said in a statement.

The facilities are designed to meet global regulatory standards, and as the other global inspections also come through, the company would have all the necessary approvals to cater to global players, he added.

"The last few quarters for our CDMO business have been eventful as we concluded various major contracts. These contracts have added new service revenues to our business and resulted in a commercial sales value of over USD 85 million in the peak year," Kumar stated.

Stelis' flagship facility (Unit 2, Bengaluru, India) is an integrated manufacturing set-up that leverages microbial and mammalian platforms for developing and commercialisng biologics and biosimilars in multiple fill-finish formats, including cartridges, devices, pre-filled syringes, liquid, and lyophilized vials.

Besides, its small-scale cGMP manufacturing facility (Unit 1, Bengaluru, India) is designed to support small-scale commercial and cGMP clinical trial material generation and initial technology transfer activities across multiple modalities.

With over USD 300 million in investments, Stelis has built a robust CDMO platform that offers one of APAC's largest drug substance capacities with over 48,000 litre across various modalities and drug product capacities exceeding 400 million units per annum.

RECENT STORIES

Gautam Adani Urges Medical Innovation, Backs Healthcare Transformation With ₹60,000 Cr Vision

Gautam Adani Urges Medical Innovation, Backs Healthcare Transformation With ₹60,000 Cr Vision

IT Department Launches ITR-2 & ITR-3 Excel Utilities, Filing Now Easier For Capital Gains & Crypto...

IT Department Launches ITR-2 & ITR-3 Excel Utilities, Filing Now Easier For Capital Gains & Crypto...

Amazon Rolls Out 10-Minute Delivery; Competition With Blinkit, Swiggy, Instamart & Zepto Intensifies

Amazon Rolls Out 10-Minute Delivery; Competition With Blinkit, Swiggy, Instamart & Zepto Intensifies

Shares Of Hindustan Unilever Surge 5% As Priya Nair Set To Become First Woman CEO & MD

Shares Of Hindustan Unilever Surge 5% As Priya Nair Set To Become First Woman CEO & MD

A Deep Dive Into India's Credit Landscape & The Journey Of A Financial Leader - Revati Kasture

A Deep Dive Into India's Credit Landscape & The Journey Of A Financial Leader - Revati Kasture